Palvella Therapeutics, Inc. (PVLA) stock
PVLANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$146.58+2.23 (+1.54%)
Close on Nov 18, 2026Market cap $2.11BP/E –Yield –
Palvella Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Palvella Therapeutics's price to sales ratio was 12.7× on Jan 31, 2025, against 0.3× a year earlier. Over the last 5 years it ranged from 0.3× to 15.9×, with a median of 3.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jan 31, 2025 | 12.7× | +1.0 |
| 2024 | Dec 31, 2024 | 11.7× | +11.4 |
| 2023 | Dec 29, 2023 | 0.3× | −2.4 |
| 2022 | Dec 30, 2022 | 2.7× | −8.2 |
| 2021 | Dec 31, 2021 | 10.9× | +7.7 |
| 2020 | Dec 31, 2020 | 3.1× | −2.1 |
| 2019 | Dec 31, 2019 | 5.3× | +1.9 |
| 2018 | Dec 31, 2018 | 3.4× | −30.9 |
| 2017 | Dec 29, 2017 | 34.3× | +22.7 |
| 2016 | Dec 30, 2016 | 11.5× | −5.4 |
| 2015 | Dec 31, 2015 | 17.0× | – |
See a number that looks wrong?